A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.
about
Innate and adaptive immunity in immune thrombocytopeniaPiecing together the humoral and cellular mechanisms of immune thrombocytopeniaThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisPlatelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengueMycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Increased number of B-cells in the red pulp of the spleen in ITP.How I manage neonatal thrombocytopenia.Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia.Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesMicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP).Pathophysiology and management of primary immune thrombocytopenia.Cellular immune dysfunction in immune thrombocytopenia (ITP).Megakaryocyte morphology and its impact in predicting response to steroid in immune thrombocytopenia.Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.Immune thrombocytopenia: recent progress in pathophysiology and treatment.Novel treatments for immune thrombocytopenia.Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia.CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.Mycophenolate mofetil therapy for severe immune thrombocytopenia.Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia.Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia.Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia.Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia.Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopeniaFetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.Mouse models of diseases of megakaryocyte and platelet homeostasis.
P2860
Q26859642-CB279662-AF42-4641-AFF3-D80D4F322A4CQ27024841-DFA7A77E-5865-4D36-99A4-D44417280F01Q28068881-4062B08E-F577-4425-945D-12B154C4C380Q30250939-35BFA70F-342E-44B3-9754-8BCF4CB7D57CQ31116844-36B35B10-292D-4390-9B4A-798A13EE90B7Q33391221-E82B9486-AE8D-4853-AE0D-6C18E2F8A681Q33393730-6610BE5C-58D6-41D5-A28C-E4C58C9CA03AQ33394438-8280DE13-504A-4BA2-B54E-E1690784CDC1Q33395863-6F0C5BEA-CC81-4C93-8762-29BF78EC77B7Q33396338-CE56E7B7-927F-41BA-A719-BA64EB59FE7FQ33397361-757B28FE-63BF-424A-AB86-DF1C0532F011Q33397882-EB92385C-AD9C-4CA7-A2D2-D5893C09E1FDQ33402209-06339895-C619-44EA-BE33-4EF42CB69E7EQ33403517-3C12B25B-924C-409F-A1AE-A87FF3E95833Q33405211-DD178034-B415-408A-B597-C3C631D0E271Q33407942-352B3B31-2CAB-44F8-B6CA-7ABF89E4E357Q33409710-493417A4-D69C-446B-8051-39E731874A65Q33411541-56A622B7-85DB-4CF5-80D3-FC66DF9ED921Q33413287-36953BE2-2034-4F3B-A2D8-116B3EF9089AQ33413317-FEC16019-2DE3-473F-BFB9-CD0FDE97F1C3Q33413896-B88E818C-D883-48D3-A418-37F7F25891BDQ33414132-67F16C18-EA58-424C-8AD6-A005AE66DE37Q33415298-951DF159-CC46-4789-9455-92D7B543BAA3Q33416544-276C6CA6-312E-431E-A65D-E885CEBE2486Q33418068-372E1095-C24C-4457-B698-CA09B93E3680Q33419269-4BFD6E54-2924-4582-8779-9D61DEEB56B2Q33422858-6F1DBF49-9297-4F06-BD6F-DC9FA5DFC98CQ33423336-F830756A-ECB8-4153-A80E-8ADE6E73BF5BQ33424988-57DD7984-8F0C-4DEC-A0C6-A0D251E57D51Q33428759-A4407BF1-B6A2-44ED-8E08-20D0347ECB65Q33432692-9D6BEF88-83D7-4287-8D96-DD67CD79ADFDQ33432917-D4DA1791-EEE9-4D25-A685-42E5D764A74AQ33433254-F8AC18D7-EFE9-4229-9873-48BC66B9172FQ33435991-70F9810C-7017-49EF-BBF9-CAA172CC64BBQ33437093-346F3439-53D6-46F9-9A59-7B8BBB8A8D42Q33439412-C972E44B-5791-495F-97AE-0AD0DCFAC53DQ33440206-8C690B32-288E-4241-9D3C-E1FAD28BA351Q33440427-19DEDB9A-5E22-4054-8453-6B6339D40F79Q33442939-5C08CB32-7829-45EE-A6FA-BA9BFDB2B055Q37888528-36648C30-1DC7-41E0-A6A2-464FBE2A94A2
P2860
A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A murine model of severe immun ...... entially sensitive to therapy.
@ast
A murine model of severe immun ...... entially sensitive to therapy.
@en
type
label
A murine model of severe immun ...... entially sensitive to therapy.
@ast
A murine model of severe immun ...... entially sensitive to therapy.
@en
prefLabel
A murine model of severe immun ...... entially sensitive to therapy.
@ast
A murine model of severe immun ...... entially sensitive to therapy.
@en
P2093
P1433
P1476
A murine model of severe immun ...... entially sensitive to therapy.
@en
P2093
Edwin R Speck
John Freedman
John W Semple
Leola Chow
M Bernadette Garvey
Michael Kim
Michelle Lee Webster
Norman Cridland
Pingguo Chen
P304
P356
10.1182/BLOOD-2009-09-244772
P407
P577
2009-12-10T00:00:00Z